enGene Holdings Statistics
Total Valuation
enGene Holdings has a market cap or net worth of $168.14 million. The enterprise value is -$23.90 million.
Important Dates
The last earnings date was Thursday, March 13, 2025.
| Earnings Date | Mar 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
enGene Holdings has 51.11 million shares outstanding. The number of shares has increased by 199.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 51.11M |
| Shares Change (YoY) | +199.07% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 26.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.66, with a Debt / Equity ratio of 0.11.
| Current Ratio | 12.66 |
| Quick Ratio | 12.11 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.39 |
Financial Efficiency
Return on equity (ROE) is -33.97% and return on invested capital (ROIC) is -21.13%.
| Return on Equity (ROE) | -33.97% |
| Return on Assets (ROA) | -20.35% |
| Return on Invested Capital (ROIC) | -21.13% |
| Return on Capital Employed (ROCE) | -35.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.40M |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, enGene Holdings has paid $248,000 in taxes.
| Income Tax | 248,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.22% in the last 52 weeks. The beta is -0.39, so enGene Holdings's price volatility has been lower than the market average.
| Beta (5Y) | -0.39 |
| 52-Week Price Change | -22.22% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 1.08 |
| Relative Strength Index (RSI) | 37.45 |
| Average Volume (20 Days) | 474 |
Short Selling Information
The latest short interest is 42,503, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 42,503 |
| Short Previous Month | 42,304 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.16% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -87.95M |
| Pretax Income | n/a |
| Net Income | -79.88M |
| EBITDA | -87.81M |
| EBIT | -87.95M |
| Earnings Per Share (EPS) | -$1.68 |
Full Income StatementBalance Sheet
The company has $217.39 million in cash and $25.36 million in debt, giving a net cash position of $192.03 million or $3.76 per share.
| Cash & Cash Equivalents | 217.39M |
| Total Debt | 25.36M |
| Net Cash | 192.03M |
| Net Cash Per Share | $3.76 |
| Equity (Book Value) | 227.29M |
| Book Value Per Share | 4.45 |
| Working Capital | 209.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$75.39 million and capital expenditures -$584,000, giving a free cash flow of -$75.98 million.
| Operating Cash Flow | -75.39M |
| Capital Expenditures | -584,000 |
| Free Cash Flow | -75.98M |
| FCF Per Share | -$1.49 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |